Compass Therapeutics, Inc.

CMPX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$49-$42-$39-$82
Dep. & Amort.$2$2$2$2
Deferred Tax$0$0$0$51
Stock-Based Comp.$9$6$5$4
Change in WC-$4-$3-$1$6
Other Non-Cash-$2$6-$1$0
Operating Cash Flow-$45-$41-$34-$20
Investing Activities
PP&E Inv.-$0-$0-$0-$2
Net Acquisitions$0$0$0$0
Inv. Purchases-$88-$155-$200$0
Inv. Sales/Matur.$135$182$49$0
Other Inv. Act.$0$0-$0-$0
Investing Cash Flow$47$27-$151-$2
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$18$3$76$128
Stock Repurch.$0-$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$1-$0-$0-$0
Financing Cash Flow$17$3$76$119
Forex Effect$0$0$0$0
Net Chg. in Cash$19-$11-$110$97
Supplemental Information
Beg. Cash$24$35$145$47
End Cash$43$24$35$145
Free Cash Flow-$45-$41-$34-$21